ResMed PE Ratio 2006-2018 | RMD

Current and historical p/e ratio for ResMed (RMD) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ResMed PE ratio as of November 19, 2018 is 27.87.
ResMed PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2018-11-19 102.57 44.21
2018-09-30 115.34 $2.32 49.72
2018-06-30 103.22 $2.19 47.13
2018-03-31 97.78 $2.14 45.69
2017-12-31 83.78 $2.00 41.89
2017-09-30 75.81 $2.47 30.69
2017-06-30 76.34 $2.41 31.68
2017-03-31 70.21 $2.29 30.66
2016-12-31 60.25 $2.30 26.19
2016-09-30 62.55 $2.40 26.06
2016-06-30 60.75 $2.43 25.00
2016-03-31 55.26 $2.45 22.56
2015-12-31 51.05 $2.46 20.75
2015-09-30 48.20 $2.46 19.59
2015-06-30 53.03 $2.47 21.47
2015-03-31 67.20 $2.47 27.20
2014-12-31 52.25 $2.46 21.24
2014-09-30 45.68 $2.42 18.87
2014-06-30 46.68 $2.40 19.45
2014-03-31 41.00 $2.29 17.91
2013-12-31 42.96 $2.24 19.18
2013-09-30 47.97 $2.17 22.10
2013-06-30 40.78 $2.10 19.42
2013-03-31 41.75 $2.13 19.60
2012-12-31 37.29 $1.99 18.74
2012-09-30 36.14 $1.88 19.22
2012-06-30 27.74 $1.72 16.13
2012-03-31 27.48 $1.56 17.62
2011-12-31 22.58 $1.46 15.47
2011-09-30 25.60 $1.41 18.15
2011-06-30 27.52 $1.44 19.11
2011-03-31 26.67 $1.41 18.92
2010-12-31 30.80 $1.39 22.24
2010-09-30 29.17 $1.32 22.18
2010-06-30 27.03 $1.23 21.98
2010-03-31 28.30 $1.19 23.88
2009-12-31 23.24 $1.13 20.66
2009-09-30 20.09 $1.05 19.23
2009-06-30 18.11 $0.95 19.06
2009-03-31 15.71 $0.85 18.59
2008-12-31 16.66 $0.78 21.36
2008-09-30 19.12 $0.73 26.19
2008-06-30 15.89 $0.71 22.54
2008-03-31 18.75 $0.69 27.18
2007-12-31 23.35 $0.40 58.38
2007-09-30 19.06 $0.42 45.92
2007-06-30 18.34 $0.42 43.67
2007-03-31 22.39 $0.40 56.69
2006-12-31 21.88 $0.67 32.90
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $14.616B $2.340B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $123.892B 25.10
Medtronic (MDT) Ireland $122.046B 18.71
Stryker (SYK) United States $62.759B 23.66
Boston Scientific (BSX) United States $48.834B 24.68
Baxter (BAX) United States $34.600B 22.34
Zimmer Biomet Holdings (ZBH) United States $23.151B 15.01
Smith & Nephew SNATS (SNN) United Kingdom $15.845B 0.00
Perrigo (PRGO) Ireland $8.530B 12.95
Bio-Rad Laboratories (BIO) United States $8.041B 51.42
Canopy Growth (CGC) Canada $7.608B 0.00
Hill-Rom Holdings (HRC) United States $6.079B 19.27
Aurora Cannabis (ACB) Canada $5.873B 32.05
Haemonetics (HAE) United States $5.316B 46.75
ICU Medical (ICUI) United States $4.835B 26.94
Insulet (PODD) United States $4.492B 0.00
Hutchison China MediTech (HCM) China $4.108B 0.00
Agios Pharmaceuticals (AGIO) United States $3.867B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.782B 0.00
Neogen (NEOG) United States $3.211B 48.63
NuVasive (NUVA) United States $3.153B 29.33
National Vision Holdings (EYE) United States $2.871B 55.54
Quidel (QDEL) United States $2.378B 31.00
Aphria (APHA) $2.260B 0.00
NxStage Medical (NXTM) United States $1.935B 0.00
Phibro Animal Health (PAHC) United States $1.371B 19.41
AtriCure (ATRC) United States $1.182B 0.00
Cardiovascular Systems (CSII) United States $0.999B 1439.50
VAREX IMAGING (VREX) United States $0.974B 19.57
Meridian Bioscience (VIVO) United States $0.833B 26.55
OraSure Technologies (OSUR) United States $0.761B 42.86
Surmodics (SRDX) United States $0.759B 115.98
Eagle Pharmaceuticals (EGRX) United States $0.737B 23.64
MacroGenics (MGNX) United States $0.713B 0.00
PetIQ (PETQ) United States $0.704B 20.01
Cerus (CERS) United States $0.692B 0.00
Lantheus Holdings (LNTH) United States $0.627B 19.41
Omeros (OMER) United States $0.617B 0.00
Owens & Minor (OMI) United States $0.546B 6.18
LeMaitre Vascular (LMAT) United States $0.537B 26.39
NanoString Technologies (NSTG) United States $0.509B 0.00
Insys Therapeutics (INSY) United States $0.499B 0.00
TG Therapeutics (TGTX) United States $0.428B 0.00
Evolus (EOLS) United States $0.377B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.342B 22.12
Cytosorbents (CTSO) United States $0.316B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.258B 0.00
Surface Oncology (SURF) United States $0.230B 0.00
Rockwell Medical (RMTI) United States $0.205B 0.00
Bovie Medical (BVX) United States $0.193B 0.00
BioLife Solutions (BLFS) United States $0.186B 250.75
Chimerix (CMRX) United States $0.168B 0.00
Fonar (FONR) United States $0.141B 7.07
Conatus Pharmaceuticals (CNAT) United States $0.136B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.116B 0.00
Chembio Diagnostics (CEMI) United States $0.108B 0.00
United-Guardian (UG) United States $0.080B 16.68
Female Health (VERU) United States $0.074B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.072B 0.00
InfuSystems Holdings (INFU) United States $0.068B 0.00
Trinity Biotech (TRIB) Ireland $0.059B 18.87
CAS Medical Systems (CASM) United States $0.051B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.027B 0.00
Myomo (MYO) United States $0.023B 0.00
Akers Biosciences Inc (AKER) United States $0.022B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.017B 0.00
Senestech (SNES) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00